- Home
- GLSI vs UCL Comparison
GLSI vs UCL Comparison
Compare GLSI & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- UCL
- Stock Information
- Founded
- GLSI 2006
- UCL 2014
- Country
- GLSI United States
- UCL Hong Kong
- Employees
- GLSI N/A
- UCL N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- GLSI Health Care
- UCL Consumer Discretionary
- Exchange
- GLSI Nasdaq
- UCL Nasdaq
- Market Cap
- GLSI 149.5M
- UCL 144.5M
- IPO Year
- GLSI 2020
- UCL 2020
- Fundamental
- Price
- GLSI $11.28
- UCL $2.16
- Analyst Decision
- GLSI Strong Buy
- UCL
- Analyst Count
- GLSI 1
- UCL 0
- Target Price
- GLSI $39.00
- UCL N/A
- AVG Volume (30 Days)
- GLSI 91.0K
- UCL 59.8K
- Earning Date
- GLSI 11-13-2025
- UCL 11-25-2025
- Dividend Yield
- GLSI N/A
- UCL N/A
- EPS Growth
- GLSI N/A
- UCL N/A
- EPS
- GLSI N/A
- UCL 0.02
- Revenue
- GLSI N/A
- UCL $89,277,000.00
- Revenue This Year
- GLSI N/A
- UCL N/A
- Revenue Next Year
- GLSI N/A
- UCL $20.86
- P/E Ratio
- GLSI N/A
- UCL $93.56
- Revenue Growth
- GLSI N/A
- UCL 3.72
- 52 Week Low
- GLSI $8.06
- UCL $0.80
- 52 Week High
- GLSI $15.47
- UCL $4.19
- Technical
- Relative Strength Index (RSI)
- GLSI 53.71
- UCL 33.21
- Support Level
- GLSI $9.73
- UCL $2.10
- Resistance Level
- GLSI $10.57
- UCL $2.44
- Average True Range (ATR)
- GLSI 0.57
- UCL 0.15
- MACD
- GLSI 0.02
- UCL -0.02
- Stochastic Oscillator
- GLSI 68.65
- UCL 8.65
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.